Ardelyx Competitors and Similar CompaniesClear all
Ardelyx's competitors and similar companies include SpectraCure.
 Ardelyx Ardelyx develops novel oral therapeutics to treat mineral metabolism and metabolic disorders. | ||
Founding Date | Founding Date 2007 | Founding Date 2003 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Fremont, US HQ Waltham, US Waltham, US | Locations HQ |
Employees | Employees 882% increase | Employees N/A |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 16.2 m |
Financial | ||
Revenue (est.) | Revenue (est.) $407.3m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $39.5m (FY, 2025) | Cost of goods kr7.2m (FY, 2025) |
Gross profit | Gross profit $367.8m (FY, 2025) | Gross profit (kr6.3m) (FY, 2025) |
Net income | Net income ($61.6m) (FY, 2025) | Net income (kr56.1m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
SpectraCure
HQ
SpectraCure is a company that provides treatment of internal solid cancer tumors.
View company